Related Experiment Video
Updated: Jul 25, 2025
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.7K
CD207 Expression Level is a New Prognostic Marker for Condyloma Acuminatum
Dong Zhang1, Yan Qu2, Changlin Sui2
1Department of Dermatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, People's Republic of China.
Clinical, Cosmetic and Investigational Dermatology
|June 29, 2023
Summary
Condyloma cuminata (CA) lesions show reduced CD207 positive cells, indicating impaired antigen presentation. Lower CD207 expression correlates with longer disease duration and increased recurrence, suggesting its potential as a prognostic marker for CA.
Area of Science:
- Dermatology
- Immunology
- Pathology
Background:
- Condyloma cuminata (CA) is a recurrent sexually transmitted infection caused by human papillomavirus (HPV).
- CD207 is a specific marker for Langerhans cells (LCs), crucial for antigen presentation in the skin.
- Current treatment for CA is challenging due to frequent recurrences.
Purpose of the Study:
- To investigate the correlation between CD207 expression in CA skin lesions and disease course.
- To determine if CD207 can serve as a prognostic marker for CA recurrence.
- To explore the role of Langerhans cells in the pathogenesis of CA.
Main Methods:
- Collected 40 male CA skin lesion samples and 40 healthy penile tissue controls.
- Confirmed CA lesions via acetic acid test and histological examination.
- Quantified CD207 expression using immunohistochemistry and analyzed correlations with disease duration and recurrence via Spearman analysis.
Main Results:
- CA skin lesions exhibited significantly fewer CD207 positive cells compared to healthy skin.
- Reduced CD207 positive cells showed morphological abnormalities, suggesting impaired LC function.
- A negative correlation was found between CD207 expression levels and both disease duration and recurrence frequency.
Conclusions:
- Decreased CD207 expression in CA lesions may indicate antigen presentation dysfunction.
- CD207 expression level is a potential novel prognostic marker for predicting CA outcomes.
- Targeting LC function could offer new therapeutic strategies for managing CA.
